Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: January 13, 2012
In 2010, the IOM released a report that found, among other things, data not being reported by sex had slowed progress in women’s health. The number of women participating in clinical trials has increased over the last two decades, though they are still underrepresented. Even when women are included in these trials, however, the results are often not analyzed separately by sex. On August 30, 2011, The IOM’s Board on Population Health and Public Health Practice hosted a workshop to address the recommendation that journals should adopt a guideline that all papers report the outcomes of research on males and females separately.
Released: December 14, 2011
Smoking-related diseases kill more Americans than alcohol, illegal drugs, murder and suicide combined. The passage of the Family Smoking Prevention and Tobacco Control Act of 2009 gave the FDA authority to regulate “modified risk tobacco products” (MRTPs), tobacco products that are either designed or advertised to reduce harm or the risk of tobacco-related disease. MRTPs must submit to the FDA scientific evidence to demonstrate the product has the potential to reduce tobacco related harms as compared to conventional tobacco products. The IOM identifies minimum standards for scientific studies that an applicant would need to complete to obtain an order to market the product from the FDA.
Released: November 30, 2011
After the September 11, 2001, terrorist attacks and subsequent anthrax mailings, the U.S. government prioritized a biosurveillance strategy aimed at detecting, monitoring, and characterizing national security health threats in human and animal populations, food, water, agriculture, and the environment. However, gaps and challenges in biosurveillance efforts and integration of biosurveillance activities remain. September 8-9, 2011, the IOM held a workshop to explore the information-sharing and collaboration processes needed for the nation’s integrated biosurveillance strategy.
Released: November 23, 2011
The completion of the initial draft of the human genome sequence in 2001 represented a fundamental shift in the way biology was studied, and allowed for vast post-genomic possibilities. Until the past decade, the work was often painstakingly slow; however, new strategies combining engineering and biological techniques have enhanced researchers' abilities. These new synthetic techniques allow for genes and long chains of DNA to be designed and manufactured from scratch using a computer and relevant chemical compounds, rather than manipulating pieces of existing genes from living cells. The IOM’s Forum on Microbial Threats hosted a public workshop March 14-15, 2011 to explore the scientific and policy dimensions of recent developments in genetic engineering and their applications to emerging infectious diseases.
Released: November 14, 2011
Nearly half of all American adults lack health literacy – an individual’s ability to obtain, process, and understand basic health information. In order to improve knowledge among these 90 million people, the IOM, along with the UCLA Anderson School of Management, held a workshop on November 30, 2010, to explore ways in which state-based organizations and individuals can work to improve health literacy.
Released: November 11, 2011
As the technology and affordability of genomic sequencing continues to evolve and the clinical applications for genomics-based research increase, it is important to address how genomics data can best be integrated into the clinical setting. On July 19, 2011, the IOM’s Roundtable on Translating Genomic-Based Research for Health hosted a workshop to highlight and identify the challenges and opportunities in integrating large-scale genomic information into clinical practice. Challenges for realizing genomic medicine range from the analysis, interpretation, and delivery of genetic information to associated workforce, ethical, and legal issues.
Released: November 08, 2011
Health IT is designed to help improve the performance of health professionals, reduce costs, and enhance patient safety. However, poorly designed health IT can create new hazards in the already complex delivery of care. In the wake of more widespread use of health IT, the Department of Health and Human Services asked the IOM to evaluate safety concerns and recommend ways to make patient care safer using health IT. The IOM makes recommendations to improve transparency in the reporting of health IT safety incidents and enhance monitoring of health IT products, both of which can lead to improved care.
Released: November 01, 2011
Several studies have found that health literacy – an individual’s ability to understand and retain information to make proper health decisions – makes a difference in how much populations use preventive services. The IOM’s Roundtable on Health Literacy held a workshop to explore approaches to integrate health literacy in to primary and secondary prevention. The workshop featured presentations and discussions on select topics related to health literacy’s role in preventive health care.
Released: October 11, 2011
Traumatic brain injury (TBI) may affect 10 million people worldwide. It is considered the “signature wound” of the conflicts in Iraq and Afghanistan. These injuries result from a bump or blow to the head, or from external forces that cause the brain to move within the head, such as whiplash or exposure to blasts. TBI can cause an array of physical and mental health concerns and is a growing problem, particularly among soldiers and veterans because of repeated exposure to violent environments. One form of treatment for TBI is cognitive rehabilitation therapy (CRT), a patient-specific, goal-oriented approach to help patients increase their ability to process and interpret information. The Department of Defense asked the IOM to conduct a study to determine the effectiveness of CRT for treatment of TBI.
Released: October 05, 2011
More than 10 years ago, the IOM released its landmark report on patient safety, To Err is Human: Building a Safer Health System. The 2011 Rosenthal Lecture featured the Honorable Kathleen G. Sebelius, Secretary of the U.S. Department of Health and Human Services, who presented the new steps that HHS is taking to improve patient safety. A panel of leaders in patient safety followed to discuss patient safety progress and opportunities.